CSIMarket
 


China Yct International Group, Inc.  (CYIG)
Other Ticker:  
 


China Yct International Group,'s ROI from its third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is China Yct International Group,'s ROI in the third quarter of 2019?
China Yct International Group, Inc. achieved a return on average invested assets (ROI) of 14.27 % in its third quarter of 2019, which is below China Yct International Group,'s average return on investment, which stands at 20.34%.

ROI has improved compared to 13.15% in the second quarter of 2019, due to net income growth.

Within the Healthcare sector 86 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2019 from 676 to 691.

Definition and Formula of Return on Investment


Return On Investment (Dec 31 2018)
III. Quarter
(Sep 30 2018)
II. Quarter
(Jun 30 2018)
I. Quarter
(Mar 31 2018)
IV. Quarter
(Dec 31 2017)
III. Quarter
Y / Y Investment Change 10.46 % 10.59 % 15.54 % 23.94 % -
Y / Y Net Income Change 56.37 % 82.42 % 17.8 % -32.15 % 10.59 %
Investment (TTM) in Millions 115 110 110 111 104
Return On Investment (TTM) 14.27 % 13.15 % 11.69 % 11.43 % 13.35 %
CYIG's Overall Ranking # 691 # 676 # 560 # 564 # 563
Seq. Investment Change 4.44 % 0.08 % -0.81 % 6.55 % 4.56 %
Seq. Net Income Change 6.41 % -9.1 % 75.05 % -7.66 % 24.14 %
Net Income (TTM) in Millions 16 14 12 12 13




Return On Investment CYIG's Ranking
Within: No.
Industry # 42
Sector # 87
Overall # 691

Return On Investment Statistics
High Average Low
81.44 %
20.34 %
7.24 %
(June 30. 2013)   (Sep 30 2016)







Financial Statements
China Yct International Group,'s III. Quarter Investments $ 115 Millions CYIG's Balance sheet
China Yct International Group,'s III. Quarter Income $ 4 Millions Quarterly CYIG's Income Statement
CYIG's Income by Division See CYIG's Income by Division


CYIG Annual Return On Investment (Mar 31 2018)
2018
(Mar 31 2017)
2017
(Mar 31 2016)
2016
(Mar 31 2015)
2015
(Mar 31 2014)
2014
Total Investments in Millions 111 90 80 75 66
Y / Y Investment Growth 23.94 % 11.62 % 6.6 % 13.61 % 15.61 %
Net Income in Millions 12 10 8 9 8
Y / Y Net Income Growth 16.75 % 19.46 % -5.33 % 9.48 % -
Annual Return On Investment 10.56 % 11.21 % 10.47 % 11.79 % 12.24 %


Annual Roi Comment
In the fiscal year 2018 ROI deteriorated to 10.56 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CYIG's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for CYIG's Competitors
Roi for China Yct International Group,'s Suppliers
Return On Investment for CYIG's Customers

Other Ratios
CYIG's Roa CYIG's Inventory Turnover Ratio CYIG's Growth Rates CYIG's Dividend Statistics
CYIG's Profitability Ratios CYIG's Asset Turnover Ratio CYIG's Dividend Growth
CYIG's Roe CYIG's Valuation Ratios CYIG's Financial Strength Ratios CYIG's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2018, within Healthcare Sector ROI
Cv Sciences Inc   37.84 %
Xtl Biopharmaceuticals Ltd   34.82 %
Molecular Templates inc   33.73 %
Align Technology inc   32.83 %
Regenxbio Inc   31.92 %
Fuse Medical Inc   31.41 %
Corcept Therapeutics Inc  30.33 %
Proteo Inc  30.29 %
Abiomed Inc   28.57 %
Regeneron Pharmaceuticals Inc   28.10 %
Tivity Health Inc   27.48 %
Mettler toledo International Inc   27.38 %
Chemed Corporation  26.69 %
Alpha Pro Tech Ltd   25.27 %
Lifevantage Corp  23.97 %
Strongbridge Biopharma plc  22.54 %
Enanta Pharmaceuticals Inc  22.52 %
Biospecifics Technologies Corp  22.39 %
Amedisys Inc   22.08 %
Aeterna Zentaris Inc   21.57 %
Scientific Industries Inc   21.36 %
Psychemedics Corp  21.29 %
Masimo Corp  21.18 %
Bristol myers Squibb Company  20.83 %
Biogen Inc   20.33 %
United Therapeutics Corporation  20.28 %
Utah Medical Products Inc  19.91 %
Stryker Corp  18.99 %
Varian Medical Systems Inc   18.83 %
3m Company  18.35 %


Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com